Logo image of ALHRG.PA

HERIGE (ALHRG.PA) Stock Fundamental Analysis

EPA:ALHRG - Euronext Paris - Matif - FR0000066540 - Common Stock - Currency: EUR

21.9  0 (0%)

Fundamental Rating

4

Taking everything into account, ALHRG scores 4 out of 10 in our fundamental rating. ALHRG was compared to 16 industry peers in the Trading Companies & Distributors industry. Both the profitability and the financial health of ALHRG get a neutral evaluation. Nothing too spectacular is happening here. ALHRG is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALHRG had positive earnings in the past year.
In the past year ALHRG had a positive cash flow from operations.
In the past 5 years ALHRG has always been profitable.
In the past 5 years ALHRG always reported a positive cash flow from operatings.
ALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

ALHRG has a Return On Assets of 3.19%. This is in the better half of the industry: ALHRG outperforms 68.75% of its industry peers.
ALHRG has a better Return On Equity (7.28%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA 3.19%
ROE 7.28%
ROIC N/A
ROA(3y)3.05%
ROA(5y)3.17%
ROE(3y)9.8%
ROE(5y)10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ALHRG.PA Yearly ROA, ROE, ROICALHRG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

With a decent Profit Margin value of 2.08%, ALHRG is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Profit Margin of ALHRG has grown nicely.
ALHRG's Gross Margin of 48.17% is amongst the best of the industry. ALHRG outperforms 100.00% of its industry peers.
ALHRG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.08%
GM 48.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.18%
PM growth 5Y11.63%
GM growth 3Y5.76%
GM growth 5Y4.96%
ALHRG.PA Yearly Profit, Operating, Gross MarginsALHRG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

ALHRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALHRG has been reduced compared to 5 years ago.
Compared to 1 year ago, ALHRG has an improved debt to assets ratio.
ALHRG.PA Yearly Shares OutstandingALHRG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALHRG.PA Yearly Total Debt VS Total AssetsALHRG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

ALHRG has an Altman-Z score of 2.63. This is not the best score and indicates that ALHRG is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.63, ALHRG perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
ALHRG has a debt to FCF ratio of 10.48. This is a negative value and a sign of low solvency as ALHRG would need 10.48 years to pay back of all of its debts.
ALHRG has a Debt to FCF ratio (10.48) which is in line with its industry peers.
A Debt/Equity ratio of 0.66 indicates that ALHRG is somewhat dependend on debt financing.
ALHRG has a Debt to Equity ratio of 0.66. This is in the lower half of the industry: ALHRG underperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 10.48
Altman-Z 2.63
ROIC/WACCN/A
WACC5.65%
ALHRG.PA Yearly LT Debt VS Equity VS FCFALHRG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALHRG has a Current Ratio of 2.46. This indicates that ALHRG is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALHRG (2.46) is better than 75.00% of its industry peers.
ALHRG has a Quick Ratio of 1.97. This is a normal value and indicates that ALHRG is financially healthy and should not expect problems in meeting its short term obligations.
ALHRG has a better Quick ratio (1.97) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.97
ALHRG.PA Yearly Current Assets VS Current LiabilitesALHRG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.08% over the past year.
ALHRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.13% yearly.
ALHRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.09%.
The Revenue has been decreasing by -3.31% on average over the past years.
EPS 1Y (TTM)15.08%
EPS 3Y-17.2%
EPS 5Y8.13%
EPS Q2Q%-2286.12%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y-9.62%
Revenue growth 5Y-3.31%
Sales Q2Q%-49.96%

3.2 Future

Based on estimates for the next years, ALHRG will show a very negative growth in Earnings Per Share. The EPS will decrease by -30.87% on average per year.
The Revenue is expected to decrease by -21.69% on average over the next years. This is quite bad
EPS Next Y-119.56%
EPS Next 2Y-30.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-25.44%
Revenue Next 3Y-21.69%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHRG.PA Yearly Revenue VS EstimatesALHRG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 200M 400M 600M 800M
ALHRG.PA Yearly EPS VS EstimatesALHRG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

ALHRG is valuated cheaply with a Price/Earnings ratio of 5.89.
ALHRG's Price/Earnings ratio is rather cheap when compared to the industry. ALHRG is cheaper than 100.00% of the companies in the same industry.
ALHRG is valuated cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
ALHRG is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.89
Fwd PE N/A
ALHRG.PA Price Earnings VS Forward Price EarningsALHRG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than ALHRG, based on the Enterprise Value to EBITDA ratio.
ALHRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALHRG is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.94
EV/EBITDA 2.5
ALHRG.PA Per share dataALHRG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The decent profitability rating of ALHRG may justify a higher PE ratio.
ALHRG's earnings are expected to decrease with -30.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.72
EPS Next 2Y-30.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALHRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERIGE

EPA:ALHRG (7/17/2025, 7:00:00 PM)

21.9

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)05-12 2025-05-12
Earnings (Next)07-21 2025-07-21
Inst Owners1.65%
Inst Owner ChangeN/A
Ins Owners18%
Ins Owner ChangeN/A
Market Cap65.48M
Analysts84.44
Price Target31.62 (44.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.88
Dividend Growth(5Y)20.75%
DP49.37%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-116.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.89
Fwd PE N/A
P/S 0.12
P/FCF 6.94
P/OCF 2.67
P/B 0.44
P/tB 0.6
EV/EBITDA 2.5
EPS(TTM)3.72
EY16.99%
EPS(NY)-1.37
Fwd EYN/A
FCF(TTM)3.15
FCFY14.4%
OCF(TTM)8.19
OCFY37.42%
SpS175.82
BVpS50.19
TBVpS36.35
PEG (NY)N/A
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 7.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.08%
GM 48.17%
FCFM 1.79%
ROA(3y)3.05%
ROA(5y)3.17%
ROE(3y)9.8%
ROE(5y)10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.18%
PM growth 5Y11.63%
GM growth 3Y5.76%
GM growth 5Y4.96%
F-Score8
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 10.48
Debt/EBITDA 3.87
Cap/Depr 38.38%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion 96%
Profit Quality 86.26%
Current Ratio 2.46
Quick Ratio 1.97
Altman-Z 2.63
F-Score8
WACC5.65%
ROIC/WACCN/A
Cap/Depr(3y)88.52%
Cap/Depr(5y)109.83%
Cap/Sales(3y)3.05%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.08%
EPS 3Y-17.2%
EPS 5Y8.13%
EPS Q2Q%-2286.12%
EPS Next Y-119.56%
EPS Next 2Y-30.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y-9.62%
Revenue growth 5Y-3.31%
Sales Q2Q%-49.96%
Revenue Next YearN/A
Revenue Next 2Y-25.44%
Revenue Next 3Y-21.69%
Revenue Next 5YN/A
EBIT growth 1Y-164.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-2.55%
EBIT Next 5YN/A
FCF growth 1Y221.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.23%
OCF growth 3Y34.8%
OCF growth 5Y-4.32%